Previously an award that was open to nomination, our team decided to keep this category but to make the award based on citation data this year.

This award recognises GenScript as the company with custom antiobdies cited more than any other. From the data generated through CiteAb we are able to gain a really clear picture of the way antibodies are used around the world. We can tell which countries are investing most in research using antibodies, which companies are seeing growth or decline, which antibodies are most successful and which areas of research are seeing growth.

Dr Andrew Chalmers, Founder of CiteAb, said: “This award goes to GenScript as the company that has secured the most custom antibody citations between 2015 and 2017. The company has clearly developed significant reach into the custom antibody market allowing them to help a large number of researchers, and I congratulate them on winning this award.”

View past winners